Arbutus Biopharma
ABUS
$2.71
Share price
1.12%
Change (1 day)
6.27%
Change (1 year)
Categories
Arbutus Biopharma (ABUS) - Total liabilities
Total liabilities on the balance sheet as of December 2023 : $38.38 M
According to Arbutus Biopharma 's latest financial reports the company's total liabilities are $38.38 M. A company’s total liabilities is the sum of all current and non-current debts and obligations.
Arbutus Biopharma - Total liabilities on balance sheet (from 2007 to 2023)
Total liabilities by year
| Year | Total liabilities | Change |
|---|---|---|
| 2023-12-31 | $38.38 M | -34.46% |
| 2022-12-31 | $58.56 M | 67.11% |
| 2021-12-31 | $35.04 M | -0.19% |
| 2020-12-31 | $35.11 M | 7.08% |
| 2019-12-31 | $32.79 M | 18.5% |
| 2018-12-31 | $27.67 M | -49.4% |
| 2017-12-31 | $54.68 M | -25% |
| 2016-12-31 | $72.91 M | -55.71% |
| 2015-12-31 | $0.16 B | 446.1% |
| 2014-12-31 | $30.14 M | 140.72% |
| 2013-12-31 | $12.52 M | 7.24% |
| 2012-12-31 | $11.67 M | 37.41% |
| 2011-12-31 | $8.49 M | -17.4% |
| 2010-12-31 | $10.28 M | 58.04% |
| 2009-12-31 | $6.5 M | 60.61% |
| 2008-12-31 | $4.05 M | -37.3% |
| 2007-12-31 | $6.46 M | 9.95% |
| 2006-12-31 | $5.87 M | -84.11% |
| 2005-12-31 | $36.98 M | -28.31% |
| 2004-12-31 | $51.59 M | 44.61% |
| 2003-12-31 | $35.67 M | 4.79% |
| 2002-12-31 | $34.04 M | 456.49% |
| 2001-12-31 | $6.11 M |
Total liabilities for similar companies or competitors
| Company | Total liabilities | differencediff. | Country |
|---|---|---|---|
 Nymox Pharmaceutical NYMX | $3.14 M | -91.80% | Bahamas |
 NRC Health
NRC | $73.48 M | 91.44% | 🇺🇸 USA |